Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353971
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-04-03
Brief Title:
A Dose Escalation Trial of Safety PharmacokineticPharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria CIndU Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Sponsor:
Jasper Therapeutics Inc
Organization:
Jasper Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-03
First Submit QC Date:
April 3 2024
Study First Post Date:
2024-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-08
Last Update Post Date:
2024-04-10
Last Update Post Date Type:
ACTUAL